Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

SELL
$22.17 - $51.8 $374,296 - $874,539
-16,883 Reduced 69.68%
7,345 $379,000
Q2 2022

Jul 29, 2022

SELL
$15.36 - $27.51 $254,438 - $455,703
-16,565 Reduced 40.61%
24,228 $600,000
Q1 2022

Apr 29, 2022

BUY
$22.22 - $39.12 $202,068 - $355,757
9,094 Added 28.69%
40,793 $1.02 Million
Q4 2021

Feb 07, 2022

SELL
$18.38 - $40.5 $1.02 Million - $2.24 Million
-55,417 Reduced 63.61%
31,699 $1.15 Million
Q3 2021

Nov 01, 2021

SELL
$13.18 - $19.83 $508,181 - $764,585
-38,557 Reduced 30.68%
87,116 $1.49 Million
Q2 2021

Aug 12, 2021

BUY
$9.59 - $50.88 $666,552 - $3.54 Million
69,505 Added 123.74%
125,673 $1.68 Million
Q1 2021

May 13, 2021

SELL
$49.53 - $68.4 $1.51 Million - $2.08 Million
-30,397 Reduced 35.11%
56,168 $2.88 Million
Q4 2020

Feb 04, 2021

BUY
$47.25 - $65.16 $2 Million - $2.76 Million
42,366 Added 95.85%
86,565 $5.36 Million
Q3 2020

Nov 09, 2020

BUY
$46.35 - $61.69 $1.61 Million - $2.15 Million
34,811 Added 370.8%
44,199 $2.42 Million
Q2 2020

Jul 20, 2020

SELL
$38.58 - $65.07 $196,140 - $330,815
-5,084 Reduced 35.13%
9,388 $540,000
Q1 2020

Apr 30, 2020

SELL
$32.73 - $50.78 $94,556 - $146,703
-2,889 Reduced 16.64%
14,472 $581,000
Q4 2019

Jan 28, 2020

SELL
$6.81 - $39.55 $54,868 - $318,654
-8,057 Reduced 31.7%
17,361 $687,000
Q3 2019

Nov 04, 2019

BUY
$6.47 - $8.96 $33,948 - $47,013
5,247 Added 26.01%
25,418 $172,000
Q2 2019

Jul 29, 2019

SELL
$8.31 - $14.85 $573 - $1,024
-69 Reduced 0.34%
20,171 $188,000
Q1 2019

Apr 29, 2019

BUY
$10.01 - $13.89 $22,712 - $31,516
2,269 Added 12.63%
20,240 $281,000
Q4 2018

Feb 01, 2019

BUY
$9.15 - $12.26 $164,434 - $220,324
17,971 New
17,971 $196,000
Q1 2018

May 03, 2018

SELL
$5.9 - $14.99 $77,366 - $196,563
-13,113 Closed
0 $0
Q4 2017

Jan 24, 2018

BUY
$5.53 - $8.42 $17,192 - $26,177
3,109 Added 31.08%
13,113 $78,000
Q3 2017

Nov 07, 2017

BUY
$6.5 - $10.69 $65,026 - $106,942
10,004
10,004 $74,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.